Hot Features
Premium
Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 141,291 |
|
|||||
| News | - | ||||||
| Day High | 0.80 | Low High |
|||||
| Day Low | 0.73 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Aligos Therapeutics Inc | ALGS | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.0197 | -2.48% | 0.7734 | 18:26:51 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.77 | 0.73 | 0.80 | 0.75 | 0.7931 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 528 | 141,291 | US$ 0.7725409 | US$ 109,153 | - | 0.5388 - 1.38 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 17:00:10 | formt | 100 | US$ 0.7734 | USD |
Aligos Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 56.75M | 75.67M | - | 15.53M | -87.68M | -1.16 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Aligos Therapeutics News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ALGS Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.05 | 1.08 | 0.73 | 0.8771638 | 246,667 | -0.2766 | -26.34% |
| 1 Month | 0.923 | 1.10 | 0.73 | 0.9770922 | 341,241 | -0.1496 | -16.21% |
| 3 Months | 0.70 | 1.20 | 0.62 | 0.8925322 | 404,483 | 0.0734 | 10.49% |
| 6 Months | 0.77 | 1.20 | 0.5388 | 0.784105 | 344,657 | 0.0034 | 0.44% |
| 1 Year | 0.95 | 1.38 | 0.5388 | 0.8753185 | 240,744 | -0.1766 | -18.59% |
| 3 Years | 21.51 | 34.31 | 0.5388 | 4.59 | 255,251 | -20.74 | -96.40% |
| 5 Years | 14.74 | 37.5099 | 0.5388 | 6.05 | 238,812 | -13.97 | -94.75% |
Aligos Therapeutics Description
| Aligos Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others. |
